According to a new market report published by Lucintel, the growth of the needle-free injection system market looks promising with opportunities in the hospitals and clinics, homecare settings, research laboratories, pharmaceutical and biotechnology companies. The global needle-free injection system market is expected to reach an estimated $6.4 billion by 2027 with a CAGR of 15.7% from 2021 to 2027. The major drivers for this market are growing prevalence of chronic diseases, the increasing incidence of communicable diseases due to needle stick injuries, and rise in demand for self-injection devices.
In this market, jet-based, spring-based, laser-powered, and vibration-based technologies are used in the needle-free injectors. On the basis of comprehensive research, Lucintel forecasts that the jet-based needle-free injector segment accounted for the largest share as it helps in preventing needlestick injuries to healthcare providers and overcomes the drawbacks of improper and unsterile reuse of needles & syringes.
Within the needle-free injection system market, fillable needle-free injectors and prefilled needle-free injectors are the major product types. The prefilled needle-free injectors segment is expected to witness the highest growth as the majority of these prefilled syringes are automated and thus reducing the risk of physical handling and ensuring a safer use.
North America is expected to remain the largest market during the forecast period mainly due growing prevalence of chronic disease and rising demand for self-injection systems contribute to driving the market. APAC is likely to witness the highest growth over the forecast period due to the expansion of private-sector hospitals and clinics to rural areas, the availability of low-cost labor for manufacturing.
Emerging trends which have a direct impact on the dynamics of the needle-free injection system industry include introduction of bubble gun and usage of highly-focused liquid microjets for needle-free injection systems. Endo International plc, Ferring Pharmaceuticals, Penjet Corporation, Medical International Technology Inc., and PharmaJet are among the major players in the needle-free injection system market.
Lucintel, a leading global strategic consulting and market research firm, has analyzed growth opportunities in the needle-free injection system market market by product, technology, usability, type of medication, site of delivery, application, end user, and region. Lucintel has prepared a comprehensive research report titled “Growth Opportunities in the Needle-Free Injection System Market 2022-2027: Trends, Forecast, and Opportunity Analysis.” This Lucintel report serves as a catalyst for growth strategy as it provides comprehensive data and analysis on trends, key drivers, and directions. The study includes trends and forecast for the needle-free injection system market by product, technology, usability, type of medication, site of delivery, application, end user, and region as follows:
By Product [Value ($ Million) from 2016 – 2027]:
Fillable Needle-Free Injectors
Prefilled Needle-Free Injectors
By Technology [Value ($ Million) from 2016 – 2027]:
Jet-Based Needle-Free Injector
Spring-Based Needle-Free Injector
Laser-Based Needle-Free Injector
Vibration-Based Needle-Free Injector
By Usability [Value ($ Million) from 2016 – 2027]:
Reusable Needle-Free Injectors
Disposable Needle-Free Injectors
By Type of Medication [Value ($ Million) from 2016 – 2027]:
Liquid-Based Needle-Free Injectors
Powder-Based Needle-Free Injectors
Projectile/Depot-Based Needle-Free Injectors
By Site of Delivery [Value ($ Million) from 2016 – 2027]:
Intradermal Injectors
Intramuscular Injectors
Subcutaneous Injectors
By Application [Value ($ Million) from 2016 – 2027]:
Vaccine Needle-Free Delivery
Insulin Needle-Free Delivery
Pain Management Needle-Free Delivery
Oncology Needle-Free Delivery
Others
By End User [Value ($ Million) from 2016 – 2027]:
Hospitals and Clinics
Homecare Settings
Research Laboratories
Pharmaceutical and Biotechnology Companies
Others
By Region [Value ($ Million) from 2016 – 2027]:
North America
United States
Canada
Mexico
Europe
Germany
France
United Kingdom
Italy
Spain
Asia Pacific
The Rest of the World
This 290-page research report will enable you to make confident business decisions in this globally competitive marketplace. For a detailed table of contents, contact Lucintel at +1-972-636-5056 or visit us at helpdesk@lucintel.com.
About Lucintel
Lucintel, the premier global Management Consulting and market research firm, creates winning strategies for growth. It offers market assessments, competitive analysis, opportunity analysis, Growth Consulting, M&A, and Due diligence services to executives and key decision makers in a variety of industries. For further information, visit www.lucintel.com.
This report addresses the following key questions:
Q.1 What are some of the most promising growth opportunities for the global needle-free injection system market by product (fillable needle-free injectors and prefilled needle-free injectors), technology (jet-based needle-free injectors, spring-based needle-free injectors, laser-powered needle-free injectors, and vibration-based needle-free injectors), usability (reusable and disposable needle-free injectors), type of medication (liquid-based needle-free injectors, powder-based needle-free injectors, and projectile/depot-based needle-free injectors), site of delivery (intradermal injectors, intramuscular injectors, and subcutaneous injectors), application (vaccine needle-free delivery, insulin needle-free delivery, pain management needle-free delivery, oncology needle-free delivery, and others), end users (hospitals and clinics, homecare settings, research laboratories, pharmaceutical and biotechnology companies, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
Q.2 Which segments will grow at a faster pace and why?
Q.3 Which region will grow at a faster pace and why?
Q.4 What are the key factors affecting market dynamics? What are the drivers and challenges, and business risks in this market?
Q.5 What are the business risks and competitive threats in this market?
Q.6 What are the emerging trends in this market and the reasons behind them?
Q.7 What are some of the changing demands of customers in the market?
Q.8 What are the new developments in the market and which companies are leading these developments?
Q.9 Who are the major players in this market? What strategic initiatives are being taken by key players for business growth?
Q.10 What are some of the competing products in this market and how big of a threat do they pose for loss of market share by product substitution?
Q.11 What M & A activity has occurred in the last 5 years?